Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report)’s stock price fell 0.9% on Thursday . The company traded as low as $3.36 and last traded at $3.42. 616,192 shares traded hands during mid-day trading, a decline of 12% from the average session volume of 700,769 shares. The stock had previously closed at $3.45.
Ono Pharmaceutical Stock Down 0.9 %
The firm’s fifty day moving average price is $3.63 and its 200-day moving average price is $4.26.
Ono Pharmaceutical Company Profile
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
Featured Stories
- Five stocks we like better than Ono Pharmaceutical
- What Investors Need to Know About Upcoming IPOs
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- Insider Trades May Not Tell You What You Think
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- What Are Growth Stocks and Investing in Them
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
